{"database": "lobbying", "table": "lobbying_activities", "rows": [[2143070, "b83e13ee-c0bf-4d04-9431-dab0b8afff05", "Q2", "THE PAUL LAXALT GROUP", 22325, "THE ROGOSIN INSTITUTE", 2018, "second_quarter", "MED", "Monitor issues concerning improvements in medical research and treatment of kidney disease. \nDialysis PATIENTS Demonstration Act of 2017 - HR 4143 and S 2065   \nThe Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 - HR 2644 and S 1980", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2018-07-12T13:40:43.570000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2143070"], "units": {}, "query_ms": 0.39709906559437513, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}